Skip to main content

Bailard, Inc.

SEC CIK
0000750641
Latest filing
Jul 30, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Bailard, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
15,437
Value
$1.40M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Bailard, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202615,437$1.40M<0.1%+3,149+25.6%AddedHolders
Q1 202612,288$984.0K<0.1%−143−1.2%ReducedHolders
Q4 202512,431$1.06M<0.1%+1,406+12.8%AddedHolders
Q3 202511,025$857.4K<0.1%+2,625+31.3%AddedHolders
Q2 20258,400$657.0K<0.1%−256−3.0%ReducedHolders
Q1 20258,656$627.4K<0.1%+660+8.3%AddedHolders
Q4 20247,996$591.9K<0.1%−31,187−79.6%ReducedHolders
Q3 202439,183$2.59M0.1%−16,043−29.0%ReducedHolders
Q2 202455,226$5.10M0.1%−530−1.0%ReducedHolders
Q1 202455,756$5.33M0.1%+6,343+12.8%AddedHolders
Q4 202349,413$3.77M0.1%−7,218−12.7%ReducedHolders
Q3 202356,631$3.92M0.1%+789+1.4%AddedHolders
Q2 202355,842$5.27M0.2%−12,750−18.6%ReducedHolders
Q1 202368,592$5.67M0.2%−360−0.5%ReducedHolders
Q4 202268,952$5.14M0.2%−1,215−1.7%ReducedHolders
Q3 202270,167$5.80M0.2%+682+1.0%AddedHolders
Q2 202269,485$6.61M0.3%+288+0.4%AddedHolders
Q1 202269,197$8.15M0.3%+2,855+4.3%AddedHolders
Q4 202166,342$8.60M0.3%−2,166−3.2%ReducedHolders
Q3 202168,508$7.76M0.3%−294−0.4%ReducedHolders
Q2 202168,802$7.13M0.2%−77−0.1%ReducedHolders
Q1 202168,879$5.76M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.